CrossrefInfokarte
Immune dysregulation in new-onset refractory status epilepticus (NORSE): current insights and therapeutic perspectives
Brain and Development · 2025-10 · 47 (5) · 104406
DOI: 10.1016/j.braindev.2025.104406 ↗Abstract
Kein Abstract verfügbar.
EUVIMED